Lido Advisors
BSX icon

Lido Advisors’s Boston Scientific BSX Stock Holding History

Lido Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.86M Buy
137,303
+8,170
+6% +$444K 0.02% 466
2026
Q1 		$8.1M Sell
129,133
-11,149
-8% -$892K 0.02% 358
2025
Q4 		$13.6M Sell
140,282
-752
-0.5% -$73.7K 0.04% 274
2025
Q3 		$13.8M Buy
141,034
+15,012
+12% +$1.55M 0.04% 253
2025
Q2 		$13.5M Sell
126,022
-11,679
-8% -$1.18M 0.05% 209
2025
Q1 		$13.9M Buy
137,701
+2,954
+2% +$297K 0.06% 192
2024
Q4 		$12M Buy
134,747
+13,018
+11% +$1.15M 0.05% 200
2024
Q3 		$10.2M Buy
121,729
+4,394
+4% +$346K 0.05% 199
2024
Q2 		$9.04M Buy
117,335
+101,587
+645% +$7.44M 0.05% 194
2024
Q1 		$1.08M Buy
15,748
+391
+3% +$25.1K 0.01% 623
2023
Q4 		$888K Buy
15,357
+2,091
+16% +$112K 0.01% 659
2023
Q3 		$700K Buy
13,266
+3,669
+38% +$192K 0.01% 648
2023
Q2 		$519K Buy
9,597
+2,519
+36% +$132K ﹤0.01% 724
2023
Q1 		$354K Sell
7,078
-2,398
-25% -$113K ﹤0.01% 822
2022
Q4 		$438K Buy
9,476
+83
+0.9% +$3.59K 0.01% 637
2022
Q3 		$363K Buy
9,393
+218
+2% +$8.74K ﹤0.01% 658
2022
Q2 		$341K Sell
9,175
-154
-2% -$6.27K ﹤0.01% 675
2022
Q1 		$413K Buy
9,329
+2,235
+32% +$96.9K ﹤0.01% 664
2021
Q4 		$301K Buy
7,094
+227
+3% +$9.54K ﹤0.01% 808
2021
Q3 		$297K Buy
6,867
+509
+8% +$22.5K ﹤0.01% 751
2021
Q2 		$272K Buy
6,358
+798
+14% +$33.6K ﹤0.01% 752
2021
Q1 		$215K Sell
5,560
-12
-0.2% -$454 ﹤0.01% 786
2020
Q4 		$200K Sell
5,572
-2,866
-34% -$103K ﹤0.01% 776
2020
Q3 		$322K Buy
8,438
+47
+0.6% +$1.81K 0.01% 464
2020
Q2 		$295K Buy
8,391
+1,976
+31% +$71.2K 0.01% 451
2020
Q1 		$209K Buy
6,415
+227
+4% +$8.87K 0.01% 506
2019
Q4 		$280K Buy
6,188
+522
+9% +$21.8K 0.01% 523
2019
Q3 		$231K Sell
5,666
-839
-13% -$35.5K 0.01% 516
2019
Q2 		$279K Buy
+6,505
New +$250K 0.02% 438

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lido Advisors's BSX Position: Q2 2026 in Review

Lido Advisors increased its Boston Scientific (BSX) stake by 6.3% in Q2 2026, buying an estimated $444K and bringing the position to 137,303 shares worth $5.86M. The position accounts for 0.02% of the portfolio, ranked #466.

Lido Advisors first reported a position in BSX in Q2 2019 and has held it in 29 quarters since. The position peaked at $13.9M in Q1 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Lido Advisors held 137,303 shares of Boston Scientific worth $5.86M as of Q2 2026.
  • Lido Advisors bought 8,170 Boston Scientific shares in Q2 2026, an estimated $444K.
  • Boston Scientific made up 0.02% of Lido Advisors's portfolio in Q2 2026, its #466 holding.
  • Lido Advisors first reported a position in Boston Scientific in Q2 2019 and has held it in 29 quarters since.
  • Lido Advisors's Boston Scientific position peaked at $13.9M in Q1 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.